Phenotyping of giant cell myocarditis versus cardiac sarcoidosis using cardiovascular magnetic resonance

Emanuele Bobbio1, Entela Bollano1, Anders Oldfors2

  • 1Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Insights

Giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) present similarly on cardiovascular magnetic resonance (CMR) imaging, making differentiation difficult. However, GCM shows more severe clinical presentation and higher biomarker levels than CS.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Inflammatory Diseases

Background:

  • Giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare, severe myocardial inflammatory diseases.
  • Limited knowledge exists regarding the cardiovascular magnetic resonance (CMR) characteristics of GCM and its differentiation from CS.

Purpose of the Study:

  • To compare the clinical and CMR findings of GCM and CS.
  • To assess the utility of CMR in distinguishing between GCM and CS.

Main Methods:

  • A blinded analysis of clinical data and CMR imaging was performed on 40 patients with biopsy-proven GCM (n=14) and CS (n=26).
  • CMR parameters assessed included ventricular dimensions, function, late gadolinium enhancement (LGE), and T2 signal intensity.

Main Results:

  • Patients with GCM and CS had similar demographics and CMR findings, including ventricular alterations and LGE patterns (e.g., "hook sign").
  • GCM cases exhibited significantly higher troponin T and natriuretic peptide levels and a worse clinical outcome compared to CS.
  • Right ventricular involvement with increased T2 signal and/or LGE was most extensive in GCM.

Conclusions:

  • CMR imaging reveals highly similar patterns for GCM and CS, challenging differentiation based solely on imaging.
  • Clinical presentation and biomarker levels appear more severe in GCM, offering potential distinguishing features.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
21
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
65